{"title":"ISB Gets $2.3 Million NIH Grant to Use Single-Cell Technology to Fight Cancer","description":"<p>ISB has received a $2.3 million NIH grant over four years in response to NCI\u2019s \u201cProvocative Questions\u201d Initiative. The project will apply ISB\u2019s most advanced single-cell omics technologies to an innovative clinical trial for colorectal cancer (ADAPT). Principal investigator Qiang Tian, MD, PhD, head of the Cancer & Stem Cell Group, explained that the goal is to identify single cell signatures that can be used to stratify those patients who respond well to the treatment from those who are resistant to the treatment. For the patients who do not respond, the hope is to figure out a better treatment scheme from the study.<\/p>","url":"https:\/\/www.systemsbiology.org\/news\/2014\/09\/22\/isb-gets-2-3-million-nih-grant-to-use-single-cell-technology-to-fight-cancer\/"}